Immunogenetics

Published on 16/03/2015 by admin

Filed under Basic Science

Last modified 16/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1157 times

CHAPTER 13 Immunogenetics

Innate Immunity

The first simple defense against infection is a mechanical barrier. The skin functions most of the time as an impermeable barrier, but in addition the acidic pH of sweat is inhibitory to bacterial growth. The membranes lining the respiratory and gastrointestinal tracts are protected by mucus. In the respiratory tract, further protection is provided by ciliary movement, whereas other bodily fluids contain a variety of bactericidal agents, such as lysozymes in tears. If an organism succeeds in invading the body, a healthy immune system reacts immediately by recognizing the alien intruder and a chain of response is triggered.

Cell-Mediated Innate Immunity

The Toll-like Receptor Pathway

A key component of cell-mediated immunity is the Toll-like receptor (TLR) pathway. TLRs are conserved transmembrane receptors which in fruit fly embryos play a critical role in dorsal-ventral development. However, their mammalian homologs function in innate immune responses and microbial recognition (in adult Drosophila, the pathway is responsible for the formation of antimicrobial peptides) and belong to the interleukin-1/TLR superfamily. The superfamily has two subgroups based on the extracellular characteristics of the receptor—i.e., whether they possess an immunoglobulin-like domain or leucine-rich repeats. TLRs typically have extracellular leucine-rich repeats.

There are 10 TLRs in man, each receptor being responsible for recognition of a specific set of pathogen-associated molecular patterns. TLR2 has been well characterised and has an essential role in the detection of invading pathogens, recognizing peptidoglycans and lipoproteins associated with gram-positive bacteria, as well as a host of other microbial and endogenous ligands. TLR2’s primary function is therefore lipoprotein-mediated signaling, and activation of the pathway by recognition of its ligand results in activation of the transcription factor NF-κB, which in turn results in the increased expression of co-stimulatory molecules and inflammatory cytokines (Figure 13.3). These cytokines help mediate migration of dendritic cells from infected tissue to lymph nodes, where they may encounter and activate leukocytes involved in the adaptive immune response. The signaling pathways used by TLRs share many of the same proteins as the interleukin-1 receptor (IL-1R) pathway (Figure 13.2). Activation of TLR leads to recruitment of the MyD88 (this is sometimes known as the MyD88-dependent pathway) which mediates the interaction between IL-1R associated kinases 1 and 4 (IRAK1 and IRAK4).

The activation of the Toll pathway has several important effects in inducing innate immunity. These effects include the production of cytokines and chemokines, including IL-1, IL-6, and TNF-α (tumor necrosis factor-alpha), which have local effects in containing infection and systemic effects with the generation of fever and induction of acute phase responses, including production of C-reactive protein. One important medical condition related to the Toll pathway is septic shock, as activation of the Toll pathway by certain ligands induces systemic release of TNF-α. There are also important health-related consequences that result from TLR2 deficiency or mutation. TLR2 deficient mice are susceptible to infection by Gram-positive bacteria as well as meningitis from Streptococcus pneumoniae.

Humoral Innate Immunity

Several soluble factors are involved in innate immunity; they help to minimize tissue injury by limiting the spread of infectious microorganisms. These are called the acute-phase proteins and include C-reactive protein, mannose-binding protein, and serum amyloid P component. The first two act by facilitating the attachment of one of the components of complement, C3b, to the surface of the microorganism, which becomes opsonized (made ready) for adherence to phagocytes, whereas the latter binds lysosomal enzymes to connective tissues. In addition, cells infected by virus synthesize and secrete interferon-α and interferon-β, which have a role in promoting the cellular response to viral infection by NK cell activation and upregulation of the MHC class I. In addition, interferon interferes with viral replication by reducing messenger RNA (mRNA) stability and interfering with translation.

Complement

The complement system is a complex of 20 or so plasma proteins that cooperate to attack extracellular pathogens. Although the critical role of the system is to opsonize pathogens, it also recruits inflammatory cells and kills pathogens directly through membrane attack complexes. The complement system can be activated through three pathways: the classical pathway, the alternative pathway, and the mannose-binding lectin (MBL) pathway (see Figure 13.3).

Complement nomenclature, like much else in immunology, can be confusing. Each component is designated by the letter C, followed by a number. But they were numbered in order of their discovery rather than the sequence of reactions. The reaction sequence is C1, C4, C3, C5, C6, C7, C8, and C9. The product of each cleavage reaction is designated by letters, the larger fragment being ‘b’ (b = big), and the smaller fragment ‘a’. In the lectin pathway, MBL in the blood binds another protein, a serine protease called MASP (MBL-associated serine protease). When MBL binds to its target (for example, mannose on the surface of a bacterium), the MASP protein functions like a convertase to clip C3 into C3a and C3b. C3 is abundant in the blood, so this happens very efficiently. The other two complement pathways also converge toward C3 convertase, which cleaves C3. C3a mediates inflammation while C3b binds to the pathogen surface, coating it and acting as an opsonin. The effector roles of the major complement proteins can be summarized according to function as follows (Figure 13.4):

There are clinical consequences relating to mutations in the genes of these pathways. The frequency of mutations of the MBL2 gene in the general population may be 5% to 10%. Although most individuals with MBL deficiency from mutations and promoter polymorphisms in MBL2 are healthy, there is an increased risk, severity, and frequency of infections and autoimmunity. The deficiency has been reported to be particularly common in infants with recurrent respiratory tract infection, otitis media, and chronic diarrhea.

Specific Acquired Immunity

Many infective microorganisms have, through mutation and selective pressures, developed strategies to overcome or evade the mechanisms associated with innate immunity. There is a need, therefore, to be able to generate specific acquired or adaptive immunity. This can, as with innate immunity, be separated into both humoral and cell-mediated processes.

Humoral Specific Acquired Immunity

The main mediators of humoral specific acquired immunity are immunoglobulins or antibodies. Antibodies are able to recognize and bind to surface antigens of infecting microorganisms, leading to the activation of phagocytes and the initiation of the classic pathway of complement, resulting in the generation of the MAC (see Figure 13.4) and availability of other complement effector functions. Exposure to a specific antigen results in the clonal proliferation of a small lymphocyte derived from the bone marrow (hence ‘B’ lymphocytes), resulting in mature antibody-producing cells or plasma cells.

Lymphocytes capable of producing antibodies express on their surface copies of the immunoglobulin (Ig) for which they code, which acts as a surface receptor for antigen. Binding of the antigen, in conjunction with other MASPs, results in signal transduction leading to the clonal expansion and production of antibody. In the first instance this results in the primary response with production of IgM and subsequently IgG. Re-exposure to the same antigen results in enhanced antibody levels in a shorter period of time, known as the secondary response, reflecting what is known as antigen-specific immunological memory.

Immunoglobulins

The immunoglobulins, or antibodies, are one of the major classes of serum protein. Their function, both in the recognition of antigenic variability and in effector activities, was initially revealed by protein studies of their structure, and later by DNA studies.

Generation of Antibody Diversity

It could seem paradoxical for a single protein molecule to exhibit sufficient structural heterogeneity to have specificity for a large number of different antigens. Different combinations of H and L chains could, to some extent, account for this diversity. It would, however, require thousands of structural genes for each chain type to provide sufficient variability for the large number of antibodies produced in response to the equally large number of antigens to which individuals can be exposed. Our initial understanding of how this could occur came from persons with a malignancy of antibody-producing cells—multiple myeloma.

DNA studies of antibody diversity

In 1965 Dreyer and Bennett proposed that an antibody could be encoded by separate ‘genes’ in germline cells that undergo rearrangement or, as they termed it, ‘scrambling’, in lymphocyte development. Comparison of the restriction maps of the DNA segments coding for the C and V regions of the immunoglobulin λ light chains in embryonic and antibody-producing cells revealed that they were far apart in the former but close together in the latter. Detailed analysis revealed that the DNA segments coding for the V and C regions of the light chain are separated by some 1500 base-pairs (bp) in antibody-producing cells. The intervening DNA segment was found to code for a joining, or J, region immediately adjacent to the V region of the light chain. The κ L-chain was shown to have the same structure. Cloning and DNA sequencing of H-chain genes in germline cells revealed that they have a fourth region, called diversity, or D, between the V and J regions.

There are estimated to be some 60 different DNA segments coding for the V region of the H-chain, 40 for the V region of the κ L-chain, and 30 for the λ L-chain V region. Six functional DNA segments code for the J region of the H-chain, five for the J region of the κ L-chain, and four for the J region of the λ L-chain. A single DNA segment codes for the C region of the κ L-chain, seven for the C region of the λ L-chain and 11 functional DNA segments code for the C region of the different classes of H-chain. There are also 27 functional DNA segments coding for the D region of the H-chain (Figure 13.6).

The genomic regions in question also contain a large number of unexpressed DNA sequences or pseudogenes (p. 17). Although the coding DNA segments for the various regions of the antibody molecule can be referred to as ‘genes’, use of this term in regard to antibodies has deliberately been avoided because they could be considered an exception to the general rule of ‘one gene–one enzyme (or protein)’ (p. 167).

The Immunoglobulin Gene Superfamily

Buy Membership for Basic Science Category to continue reading. Learn more here